AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 16258094 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk-adapted alternating short-course multiagent systemic and intrathecal chemotherapy, cranial irradiation if indicated, and conventional maintenance therapy.
Number of subjects: 183
Study 16258094 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk-adapted treatment for group A (early BM relapse).
Number of subjects: 183
Study 16258094 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk-adapted treatment for group B (late BM relapse).
Number of subjects: 183
Study 16258094 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk-adapted treatment for group C (isolated extramedullary relapse).
Number of subjects: 183
Study 16258094 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk-adapted treatment with individual regimens for 24 patients with exceptionally poor prognosis.
Number of subjects: 183
Study 12079437 — intervention group
Group type: EXPERIMENTAL
Intervention: NCEP step I diet with supervised aerobic exercise program
Number of subjects: 41
Study 12079437 — intervention group
Group type: EXPERIMENTAL
Intervention: NCEP step II diet with supervised aerobic exercise program
Number of subjects: 41
Study 12079437 — intervention group
Group type: COMPARATOR
Intervention: NCEP step I diet with regular exercise (standard lifestyle recommendations)
Number of subjects: 41
Study 12079437 — intervention group
Group type: EXPERIMENTAL
Intervention: NCEP step II diet without supervised aerobic exercise program
Number of subjects: 41
Study 9515848 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional nCPAP
Number of subjects: 50
Study 9515848 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-adjusting nCPAP
Number of subjects: 50
Study 8062153 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipriflavone (IP) 600 mg/day
Number of subjects: 40
Study 8062153 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 40
Study 3178248 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone plus ten large-volume plasma exchanges over four weeks
Number of subjects: 40
Study 3178248 — intervention group
Group type: COMPARATOR
Intervention: Prednisolone alone
Number of subjects: 40
Study 4758424 — intervention group
Group type: EXPERIMENTAL
Intervention: Lanoxin tablets produced between 1969 and 1972 (1.5 mg dose)
Number of subjects: 0
Study 4758424 — intervention group
Group type: EXPERIMENTAL
Intervention: Recently produced Lanoxin tablets (1.5 mg dose)
Number of subjects: 0
Study 4758424 — intervention group
Group type: COMPARATOR
Intervention: Recent independently produced batches of Lanoxin tablets (0.5 mg dose)
Number of subjects: 0
Study 31939326 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast-track surgery combined with a clinical nursing pathway
Number of subjects: 70
Study 31939326 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing during the perioperative period
Number of subjects: 70
Study 31270732 — intervention group
Group type: EXPERIMENTAL
Intervention: eCoFit smartphone application and integrated group sessions (weeks 1-10)
Number of subjects: 84
Study 31270732 — intervention group
Group type: EXPERIMENTAL
Intervention: eCoFit smartphone application only (weeks 11-20)
Number of subjects: 84
Study 28120630 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropinirole PR 16 mg
Number of subjects: 0
Study 28120630 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropinirole PR 8 mg
Number of subjects: 0
Study 28120630 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropinirole PR (all doses)
Number of subjects: 0
Study 28120630 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 25641537 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-sodium diet (1500 mg/d)
Number of subjects: 38
Study 25641537 — intervention group
Group type: COMPARATOR
Intervention: Moderate-sodium diet (2300 mg/d)
Number of subjects: 38
Study 24154787 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor 180 mg
Number of subjects: 100
Study 24154787 — intervention group
Group type: COMPARATOR
Intervention: Prasugrel 60 mg
Number of subjects: 100
Study 22707609 — intervention group
Group type: EXPERIMENTAL
Intervention: Belimumab 1 mg/kg
Number of subjects: 0
Study 22707609 — intervention group
Group type: EXPERIMENTAL
Intervention: Belimumab 10 mg/kg
Number of subjects: 0
Study 22707609 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 19450919 — intervention group
Group type: EXPERIMENTAL
Intervention: 17-betaestradiol 0.01%
Number of subjects: 36
Study 19450919 — intervention group
Group type: COMPARATOR
Intervention: Isoflavones 40% (genistein 4%)
Number of subjects: 36
Study 17968793 — intervention group
Group type: EXPERIMENTAL
Intervention: Type 2 distal fibular physis position
Number of subjects: 30
Study 17968793 — intervention group
Group type: EXPERIMENTAL
Intervention: Type 3 distal fibular physis position
Number of subjects: 30
Study 17968793 — intervention group
Group type: COMPARATOR
Intervention: Type 1 distal fibular physis position
Number of subjects: 30
Study 15633711 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose anti-snake venom (6 vials)
Number of subjects: 100
Study 15633711 — intervention group
Group type: COMPARATOR
Intervention: High-dose anti-snake venom (12 vials)
Number of subjects: 100
Study 11502921 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamotrigine (titrated from 25 to 400 mg/day)
Number of subjects: 59
Study 11502921 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study 11502921 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamotrigine
Number of subjects: 59
Study 11502921 — intervention group
Group type: COMPARATOR
Intervention: Lamotrigine and Placebo
Number of subjects: 59
Study 9013103 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy (LC)
Number of subjects: 28
Study 9013103 — intervention group
Group type: COMPARATOR
Intervention: Open cholecystectomy (OC)
Number of subjects: 28
Study 7930196 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 76
Study 7930196 — intervention group
Group type: COMPARATOR
Intervention: Hydralazine
Number of subjects: 76
Study 3355738 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycopyrrolate 0.01 mg kg‐1
Number of subjects: 40
Study 3355738 — intervention group
Group type: COMPARATOR
Intervention: Atropine 0.02 mg kg‐1
Number of subjects: 40
Study 2334627 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3‐molar sodium citrate 15 ml (sodium citrate 1.16 g)
Number of subjects: 147
Study 2334627 — intervention group
Group type: EXPERIMENTAL
Intervention: effervescent cimetidine‐sodium citrate combination (cimetidine 400 mg with sodium citrate 0.9 g)
Number of subjects: 147
Study 2334627 — intervention group
Group type: COMPARATOR
Intervention: no premedication
Number of subjects: 147
Study 1094842 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg of methylphenidate daily
Number of subjects: 8
Study 1094842 — intervention group
Group type: EXPERIMENTAL
Intervention: methylphenidate alone
Number of subjects: 8
Study 1094842 — intervention group
Group type: COMPARATOR
Intervention: 160 mg of caffeine
Number of subjects: 8
Study 1094842 — intervention group
Group type: COMPARATOR
Intervention: decaffeinated coffee
Number of subjects: 8
Study 1094842 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 8
Study 31495254 — intervention group
Group type: EXPERIMENTAL
Intervention: Reproductive life plan counseling (RLPC)
Number of subjects: 1946
Study 31495254 — intervention group
Group type: COMPARATOR
Intervention: Standard contraceptive counseling
Number of subjects: 1946
Study 28879243 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) resource
Number of subjects: 56
Study 25701265 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise and nicotine lozenge
Number of subjects: 30
Study 25701265 — intervention group
Group type: COMPARATOR
Intervention: Nicotine lozenge alone
Number of subjects: 30
Study 23586977 — intervention group
Group type: EXPERIMENTAL
Intervention: Er:YAG laser short pulse (SP)
Number of subjects: 150
Study 23586977 — intervention group
Group type: EXPERIMENTAL
Intervention: Er:YAG laser super short pulse (SSP)
Number of subjects: 150
Study 23586977 — intervention group
Group type: EXPERIMENTAL
Intervention: sandblasted
Number of subjects: 150
Study 23586977 — intervention group
Group type: EXPERIMENTAL
Intervention: sandblasted+SP
Number of subjects: 150
Study 23586977 — intervention group
Group type: EXPERIMENTAL
Intervention: sandblasted+SSP
Number of subjects: 150
Study 23586977 — intervention group
Group type: COMPARATOR
Intervention: Transbond XT (control group)
Number of subjects: 150
Study 23586977 — intervention group
Group type: EXPERIMENTAL
Intervention: RelyX U 200
Number of subjects: 150
Study 21269578 — intervention group
Group type: EXPERIMENTAL
Intervention: Second TNF-alpha inhibitor
Number of subjects: 4441
Study 19713451 — intervention group
Group type: EXPERIMENTAL
Intervention: Exogenous natural porcine surfactant HL 10
Number of subjects: 418
Study 19713451 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 418
Study 17429084 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy plus supportive care
Number of subjects: 85
Study 17429084 — intervention group
Group type: COMPARATOR
Intervention: Supportive care alone
Number of subjects: 85
Study 16042672 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist-led pharmaceutical care programme
Number of subjects: 208
Study 16042672 — intervention group
Group type: COMPARATOR
Intervention: Traditional services
Number of subjects: 208
Study 11124747 — intervention group
Group type: EXPERIMENTAL
Intervention: High-procyanidin chocolate (4.0 mg/g)
Number of subjects: 10
Study 11124747 — intervention group
Group type: EXPERIMENTAL
Intervention: In vitro procyanidin treatment
Number of subjects: 10
Study 9609623 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamsulosin 0.4 mg/day
Number of subjects: 756
Study 9609623 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamsulosin 0.8 mg/day
Number of subjects: 756
Study 9609623 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 756
Study 7840686 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactate dehydrogenase (LDH)
Number of subjects: 3
Study 7840686 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxybutyrate dehydrogenase (HBDH)
Number of subjects: 3
Study 7840686 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal controls)
Number of subjects: 3
Study 7840686 — intervention group
Group type: COMPARATOR
Intervention: Asymptomatic carrier group
Number of subjects: 3
Study 3122698 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion hydrochloride
Number of subjects: 11
Study 28853196 — intervention group
Group type: EXPERIMENTAL
Intervention: LSSM arm (n=274)
Number of subjects: 548
Study 28853196 — intervention group
Group type: COMPARATOR
Intervention: Conventional arm (n=274)
Number of subjects: 548
Study 27810187 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium Oxybate (SXB)
Number of subjects: 222
Study 27810187 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium Oxybate (SXB) + Modafinil
Number of subjects: 222
Study 27810187 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 222
Study 22834968 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab 80 mg followed by 40 mg every other week for 7 weeks
Number of subjects: 20
Study 22834968 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 22559856 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine (1.5 mg/kg)
Number of subjects: 240
Study 22559856 — intervention group
Group type: COMPARATOR
Intervention: Intravenous morphine (0.1 mg/kg)
Number of subjects: 240
Study 19959611 — intervention group
Group type: EXPERIMENTAL
Intervention: Interdental brush with a short curved handle and triangular cross-section (IDB)
Number of subjects: 110
Study 19959611 — intervention group
Group type: COMPARATOR
Intervention: Monotufted brush head (MTB)
Number of subjects: 110
Study 19959611 — intervention group
Group type: EXPERIMENTAL
Intervention: Interdental brush (IDB)
Number of subjects: 110
Study 17666252 — intervention group
Group type: EXPERIMENTAL
Intervention: Bipolar radiofrequency volumetric tissue reduction (RFVTR) using Coblator II ENT
Number of subjects: 150
Study 17666252 — intervention group
Group type: COMPARATOR
Intervention: Monopolar radiofrequency volumetric tissue reduction (RFVTR) using Somnoplasty
Number of subjects: 150
Study 16199715 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective head cooling (SHC)
Number of subjects: 86
Study 16199715 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body cooling (WBC)
Number of subjects: 86
Study 16199715 — intervention group
Group type: COMPARATOR
Intervention: Noncooled infants
Number of subjects: 86
Study 11862974 — intervention group
Group type: EXPERIMENTAL
Intervention: Peritoneal dialysis solution containing amino acids and bicarbonate
Number of subjects: 11
Study 11862974 — intervention group
Group type: EXPERIMENTAL
Intervention: Peritoneal dialysis solution containing glucose and bicarbonate
Number of subjects: 11
Study 11862974 — intervention group
Group type: COMPARATOR
Intervention: Peritoneal dialysis solution containing glucose and lactate
Number of subjects: 11
Study 10556990 — intervention group
Group type: EXPERIMENTAL
Intervention: MUFA diet (40 E% fat, 25 E% as MUFA, 45 E% carbohydrate, 15 E% protein)
Number of subjects: 16
Study 10556990 — intervention group
Group type: COMPARATOR
Intervention: CHO diet (55 E% carbohydrate, 30 E% fat, 15 E% protein)
Number of subjects: 16
Study 10556990 — intervention group
Group type: EXPERIMENTAL
Intervention: Both diets (MUFA and CHO)
Number of subjects: 16
Study 8753945 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorazepam
Number of subjects: 26
Study 8753945 — intervention group
Group type: COMPARATOR
Intervention: None (Control)
Number of subjects: 26
Study 1861487 — intervention group
Group type: EXPERIMENTAL
Intervention: Phase I exercise therapy
Number of subjects: 30
Study 1861487 — intervention group
Group type: COMPARATOR
Intervention: Ward activities and ad libitum walking (Control)
Number of subjects: 30
Study 6401392 — intervention group
Group type: EXPERIMENTAL
Intervention: Total parenteral nutrition
Number of subjects: 27
Study 6401392 — intervention group
Group type: COMPARATOR
Intervention: Conventional oral nutrition (Control)
Number of subjects: 27
Study 31689513 — intervention group
Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT) as an adjunct to full-mouth scaling (FMS)
Number of subjects: 50
Study 31689513 — intervention group
Group type: COMPARATOR
Intervention: Full-mouth scaling (FMS) alone
Number of subjects: 50
Study 28067467 — intervention group
Group type: EXPERIMENTAL
Intervention: Image guidance using CMUD (Sonic Window©) for 3 weeks
Number of subjects: 0
Study 28067467 — intervention group
Group type: COMPARATOR
Intervention: Standard cannulation (control group) for 3 weeks
Number of subjects: 0
Study 26493094 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole (adjuvant therapy)
Number of subjects: 0
Study 26493094 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen (adjuvant therapy)
Number of subjects: 0
Study 24912399 — intervention group
Group type: COMPARATOR
Intervention: Conventional group (2-adhesive retainer design)
Number of subjects: 84
Study 24912399 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed group (combining adhesive retainer with a crown or partial crown)
Number of subjects: 84
Study 24912399 — intervention group
Group type: COMPARATOR
Intervention: Conventional group
Number of subjects: 84
Study 24912399 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed group
Number of subjects: 84
Study 22335305 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% chlorhexidine (CHX) applied for 60 seconds on acid-etched dentin in ARC/CHX group
Number of subjects: 10
Study 22335305 — intervention group
Group type: EXPERIMENTAL
Intervention: 24% ethylenediamine tetra‐acetic acid gel (EDTA) applied for 45 seconds on smear-covered dentin in U100/EDTA group
Number of subjects: 10
Study 22335305 — intervention group
Group type: COMPARATOR
Intervention: No pretreatment (control)
Number of subjects: 10
Study 22335305 — intervention group
Group type: EXPERIMENTAL
Intervention: RelyX ARC (ARC)
Number of subjects: 10
Study 22335305 — intervention group
Group type: EXPERIMENTAL
Intervention: RelyX U100 (U100)
Number of subjects: 10
Study 20699022 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic reminder for further diagnostics of Lynch syndrome
Number of subjects: 0
Study 20699022 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 17629926 — intervention group
Group type: EXPERIMENTAL
Intervention: Echocardiography (US) using Teichholz's M-mode formula
Number of subjects: 135
Study 17629926 — intervention group
Group type: COMPARATOR
Intervention: Cardiac Magnetic Resonance (CMR) imaging
Number of subjects: 135
Study 17629926 — intervention group
Group type: EXPERIMENTAL
Intervention: Echocardiography (US)
Number of subjects: 135
Study 15738748 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine (FLU)
Number of subjects: 62
Study 15738748 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 62
Study 12196418 — intervention group
Group type: EXPERIMENTAL
Intervention: AHA step 2 diet plus endurance exercise (1 hour, three times a week)
Number of subjects: 64
Study 12196418 — intervention group
Group type: COMPARATOR
Intervention: AHA step 1 diet plus stretching exercise (control group)
Number of subjects: 64
Study 10442214 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical evening primrose oil in a stable water-in-oil emulsion
Number of subjects: 20
Study 10442214 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical evening primrose oil in an amphiphilic emulsion
Number of subjects: 20
Study 10442214 — intervention group
Group type: COMPARATOR
Intervention: Vehicle control (amphiphilic emulsion)
Number of subjects: 20
Study 10442214 — intervention group
Group type: COMPARATOR
Intervention: Vehicle control (stable water-in-oil emulsion)
Number of subjects: 20
Study 7570970 — intervention group
Group type: EXPERIMENTAL
Intervention: Sandimmun Neoral
Number of subjects: 57
Study 7570970 — intervention group
Group type: COMPARATOR
Intervention: Regular Sandimmun
Number of subjects: 57
Study 2139858 — intervention group
Group type: EXPERIMENTAL
Intervention: terfenadine
Number of subjects: 30
Study 2139858 — intervention group
Group type: EXPERIMENTAL
Intervention: ipratropium bromide
Number of subjects: 30
Study 2139858 — intervention group
Group type: COMPARATOR
Intervention: distilled water challenge (control)
Number of subjects: 30
Study 375178 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparinized fluids (1 unit/ml)
Number of subjects: 62
Study 375178 — intervention group
Group type: COMPARATOR
Intervention: Nonheparinized fluids
Number of subjects: 62
Study 30652949 — intervention group
Group type: EXPERIMENTAL
Intervention: Speed of processing (SOP) training with transcranial direct current stimulation (tDCS)
Number of subjects: 66
Study 30652949 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 66
Study 30609322 — intervention group
Group type: EXPERIMENTAL
Intervention: Violet noise
Number of subjects: 24
Study 30609322 — intervention group
Group type: EXPERIMENTAL
Intervention: White noise
Number of subjects: 24
Study 30609322 — intervention group
Group type: EXPERIMENTAL
Intervention: Brown noise
Number of subjects: 24
Study 28067762 — intervention group
Group type: EXPERIMENTAL
Intervention: 12% carbohydrate solution (CHO)
Number of subjects: 16
Study 28067762 — intervention group
Group type: COMPARATOR
Intervention: Non-caloric taste matched placebo (PLA)
Number of subjects: 16
Study 25772627 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Nurture Intervention (FNI)
Number of subjects: 105
Study 25772627 — intervention group
Group type: COMPARATOR
Intervention: Standard Care (SC)
Number of subjects: 105
Study 23810332 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential chemoradiation
Number of subjects: 271
Study 23810332 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternating chemoradiation
Number of subjects: 271
Study 23810332 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality assurance program
Number of subjects: 271
Study 21672303 — intervention group
Group type: EXPERIMENTAL
Intervention: Bronchial thermoplasty (BT)
Number of subjects: 421
Study 21672303 — intervention group
Group type: COMPARATOR
Intervention: Standard medications and sham BT treatment
Number of subjects: 421
Study 19220774 — intervention group
Group type: EXPERIMENTAL
Intervention: IL13 p.R130Q and c.1‐1111C>T variants
Number of subjects: 453
Study 17023001 — intervention group
Group type: EXPERIMENTAL
Intervention: Unipolar depressed in-patients
Number of subjects: 38
Study 17023001 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 38
Study 15088885 — intervention group
Group type: EXPERIMENTAL
Intervention: Scaling and root planing followed by local application of doxycycline (SRP-D)
Number of subjects: 43
Study 15088885 — intervention group
Group type: COMPARATOR
Intervention: Scaling and root planing (SRP)
Number of subjects: 43
Study 11576155 — intervention group
Group type: EXPERIMENTAL
Intervention: ST/HR slope ≤‐2.4 μV · bpm‐1
Number of subjects: 116
Study 11576155 — intervention group
Group type: EXPERIMENTAL
Intervention: ST-deficit
Number of subjects: 116
Study 11576155 — intervention group
Group type: EXPERIMENTAL
Intervention: Cumulative HR adjusted criteria
Number of subjects: 116
Study 11576155 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean ST-deficit
Number of subjects: 116
Study 9572419 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 IU rhFSH
Number of subjects: 67
Study 9572419 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study 9175962 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% Diprivan mixed with 1% lignocaine
Number of subjects: 71
Study 9175962 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% Diprivan mixed with hydrochloric acid
Number of subjects: 71
Study 9175962 — intervention group
Group type: COMPARATOR
Intervention: 1% Diprivan mixed with saline
Number of subjects: 71
Study 1903616 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentigetide, 0.5%, ophthalmic solution
Number of subjects: 50
Study 1903616 — intervention group
Group type: COMPARATOR
Intervention: Cromolyn sodium, 4%, ophthalmic solution
Number of subjects: 50
Study 7033782 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjusted doses of heparin
Number of subjects: 106
Study 7033782 — intervention group
Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 106
Study 7033782 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin
Number of subjects: 106
Study 31103129 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracic spine self-mobilization
Number of subjects: 52